Evidence map›Paper›PMID 39420004›Full record

ArticleNature communications2024

OTUD5 promotes end-joining of deprotected telomeres by promoting ATM-dependent phosphorylation of KAP1

Shiu Yeung Lam, Ruben van der Lugt, Aurora Cerutti, Zeliha Yalçin, Alexander M Thouin, Marco Simonetta, Jacqueline J L Jacobs

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Evolution ofInternational journal of molecular sciences · 2026
    Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shiu Yeung Lam *Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.ORCID 0000-0003-3001-3112
Ruben van der Lugt *Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Aurora CeruttiDivision of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Zeliha YalçinDivision of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.ORCID 0000-0001-9780-0140
Alexander M ThouinDivision of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.ORCID 0000-0002-9331-4898
Marco SimonettaDivision of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Jacqueline J L JacobsDivision of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. j.jacobs@nki.nl.ORCID 0000-0002-7704-4795

Funding

Dutch Ministry of Health, Welfare and Sport | Rijksinstituut voor Volksgezondheid en Milieu (Netherlands National Institute for Public Health and the Environment) Institutional grant to the Netherlands Cancer InstituteEC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 Marie Skłodowska-Curie Actions (H2020 Excellent Science - Marie Skłodowska-Curie Actions) 812829KWF Kankerbestrijding (Dutch Cancer Society) 2019-2/12826KWF Kankerbestrijding (Dutch Cancer Society) institutional grant to the Netherlands Cancer Institute
6 · The paper itself

Abstract

Appropriate repair of damaged DNA and the suppression of DNA damage responses at telomeres are essential to preserve genome stability. DNA damage response (DDR) signaling consists of cascades of kinase-driven phosphorylation events, fine-tuned by proteolytic and regulatory ubiquitination. It is not fully understood how crosstalk between these two major classes of post-translational modifications impact DNA repair at deprotected telomeres. Hence, we performed a functional genetic screen to search for ubiquitin system factors that promote KAP1

Indexed as

Ataxia Telangiectasia Mutated ProteinsDNA End-Joining RepairTelomereTripartite Motif-Containing Protein 28DNA DamageEndopeptidasesHEK293 CellsHeterochromatinHumansPhosphorylationUbiquitinationUbiquitin-Protein LigasesAtaxia Telangiectasia Mutated ProteinsATM protein, humanEndopeptidasesHeterochromatinOTUD5 protein, humanTRIM28 protein, humanTripartite Motif-Containing Protein 28Ubiquitin-Protein Ligases

Identifiers

PMID39420004
PMCPMC11486905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.